ArticleJournal of computer-aided molecular design2026
Quantifying conformational diversity in protein-ligand ensembles for structure-based virtual screening.
Article in Journal of computer-aided molecular design, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Structure-based virtual screening (SBVS) requires accurate representations of protein and ligand conformational states, since both components can adopt diverse geometries that influence binding energetics. Using 79 HIV-1 protease-ligand complexes, we quantify how conformational heterogeneity and ensemble clustering shape the evaluation of interaction energies by comparing native complexes, nonnative pairings, protein ensembles derived from apo MD, and ligand ensembles sampled in solution. Native complexes consistently yield favorable interactions, whereas nonnative pairings are rarely favorable and often highly unfavorable, indicating that many failures in screening that uses a single structure arise from protein-ligand geometric mismatch rather than from the scoring function alone. We further show that structural reduction of protein and ligand ensembles decreases the recovery of favorable interaction states, and that simultaneous reduction of both ensembles constrains the availability of complementary structural pairs. Because SBVS is often limited by computational cost, receptor ensembles are typically restricted to a small number of conformations. Here, we quantify the sampling scale and the level of ensemble reduction required to retain binding-compatible geometries and stable interaction-energy trends, providing practical guidance for ensemble-based screening.
Indexed as
Identifiers
42032379What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.